04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
It’s hard to keep up with all the recent changes to labor and employment law. While the law always ...
Read More >
Seyfarth Synopsis: As the Massachusetts Paid Family and Medical Leave (“PFML”) law enters the firs...
Read More >
What’s the Deal? Special purpose acquisition companies (“SPACs”), commonly referred to as “blan...
Read More >
The Third Circuit recently opened the door to exempting Uber drivers from the Federal Arbitration Ac...
Read More >
The Oregon Supreme Court just revived a whistleblower retaliation claim filed against sportswear gia...
Read More >
The Internal Revenue Service has extended the due date for providing the 2019 Form 1095-C (applicabl...
Read More >